Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Revisió basada en PRISMA× | Revisió ràpida× | |
|---|---|---|
| Camp | Cienciometria | Cienciometria |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 2009 (original PRISMA statement); updated 2020 | 2000s (rapidly adopted after 2005; Cochrane guidance 2020–2021) |
| Autor original≠ | David Moher and PRISMA Group | Developed and formalised by health technology assessment agencies and the Cochrane Collaboration |
| Tipus≠ | Structured reporting framework for systematic reviews | Evidence synthesis review |
| Font seminal≠ | Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. DOI ↗ | Garritty, C., Gartlehner, G., Nussbaumer-Streit, B., King, V. J., Hamel, C., Kamel, C., Affengruber, L., & Stevens, A. (2021). Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. Journal of Clinical Epidemiology, 130, 13–22. DOI ↗ |
| Àlies | PRISMA review, PRISMA-guided systematic review, PRISMA 2020 review, PRISMA-compliant review | rapid evidence review, accelerated systematic review, rapid evidence assessment, REA |
| Relacionats | 5 | 5 |
| Resum≠ | A PRISMA-based review is a systematic literature review conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Originally published by Moher et al. in 2009 and updated as PRISMA 2020 by Page et al., the framework specifies a 27-item checklist and a four-phase flow diagram covering identification, screening, eligibility, and inclusion — ensuring full transparency and reproducibility in the review process. | A rapid review is a streamlined form of systematic review that deliberately simplifies or omits certain steps — such as dual screening, exhaustive grey-literature search, or full risk-of-bias assessment — in order to deliver timely, policy-relevant evidence synthesis within weeks rather than years. It is increasingly used by health agencies, governments, and organisations facing urgent decision-making needs where a full systematic review is not feasible within the available time and resources. |
| ScholarGateConjunt de dades ↗ |
|
|